216 related articles for article (PubMed ID: 23219284)
61. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
Nissen SE; Wolski KE; Prcela L; Wadden T; Buse JB; Bakris G; Perez A; Smith SR
JAMA; 2016 Mar; 315(10):990-1004. PubMed ID: 26954408
[TBL] [Abstract][Full Text] [Related]
62. Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide.
DeQuattro V
Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV28-32; discussion IV51-5. PubMed ID: 1893639
[TBL] [Abstract][Full Text] [Related]
63. Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.
Lee IT; Sheu WH; Hung YJ; Chen JF; Wang CY; Lee WJ
Dis Markers; 2015; 2015():780743. PubMed ID: 25918454
[TBL] [Abstract][Full Text] [Related]
64. Effectiveness of Valsartan/Amlodipine Single-pill Combination in Hypertensive Patients With Excess Body Weight: Subanalysis of China Status II.
Ge B; Peng W; Zhang Y; Wen Y; Liu C; Guo X
J Cardiovasc Pharmacol; 2015 Nov; 66(5):497-503. PubMed ID: 26248276
[TBL] [Abstract][Full Text] [Related]
65. Ramipril/amlodipine single pill - effectiveness, tolerance and patient satisfaction with antihypertensive therapy in relation to nutritional status.
Olszanecka-Glinianowicz M; Smertka M; Almgren-Rachtan A; Chudek J
Pharmacol Rep; 2014 Dec; 66(6):1043-9. PubMed ID: 25443733
[TBL] [Abstract][Full Text] [Related]
66. Long-term effects of antihypertensive therapy on cardiovascular events and new-onset diabetes mellitus in high-risk hypertensive patients in Japan.
Liu J; Yasuno S; Oba K; Konda M; Ichihara C; Kitao H; Kuwabara Y; Ueshima K
J Hypertens; 2018 Sep; 36(9):1921-1928. PubMed ID: 29750680
[TBL] [Abstract][Full Text] [Related]
67. [Unexpected study data for treatment of hypertension. Combination therapy with a diuretic not imperative].
Aumiller J
MMW Fortschr Med; 2008 Jun; 150(23):46-7. PubMed ID: 18575372
[No Abstract] [Full Text] [Related]
68. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Poulter NR; Wedel H; Dahlöf B; Sever PS; Beevers DG; Caulfield M; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; Pocock S;
Lancet; 2005 Sep 10-16; 366(9489):907-13. PubMed ID: 16154017
[TBL] [Abstract][Full Text] [Related]
69. ACCOMPLISH the goal: hypertension and beyond.
Siragy HM
Curr Hypertens Rep; 2009 Aug; 11(4):231-2. PubMed ID: 19602321
[No Abstract] [Full Text] [Related]
70. The first hypertension trial comparing the effects of two fixed-dose combination therapy regimens on cardiovascular events: Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH).
Jamerson KA;
J Clin Hypertens (Greenwich); 2003; 5(4 Suppl 3):29-35. PubMed ID: 12941995
[TBL] [Abstract][Full Text] [Related]
71. Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients.
Tepel M; Hopfenmueller W; Scholze A; Maier A; Zidek W
Nephrol Dial Transplant; 2008 Nov; 23(11):3605-12. PubMed ID: 18511605
[TBL] [Abstract][Full Text] [Related]
72. [Fatal subfulminant hepatitis probably due to the combination benazepril-hydrochlorothiazide (Briazide)].
Hourmand-Ollivier I; Dargere S; Cohen D; Galais MP; Mosquet B; Rousselot P; Dao T
Gastroenterol Clin Biol; 2000 Apr; 24(4):464. PubMed ID: 10844292
[No Abstract] [Full Text] [Related]
73. Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
Bohula EA; Wiviott SD; McGuire DK; Inzucchi SE; Kuder J; Im K; Fanola CL; Qamar A; Brown C; Budaj A; Garcia-Castillo A; Gupta M; Leiter LA; Weissman NJ; White HD; Patel T; Francis B; Miao W; Perdomo C; Dhadda S; Bonaca MP; Ruff CT; Keech AC; Smith SR; Sabatine MS; Scirica BM;
N Engl J Med; 2018 Sep; 379(12):1107-1117. PubMed ID: 30145941
[TBL] [Abstract][Full Text] [Related]
74. Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
Bohula EA; Scirica BM; Fanola C; Inzucchi SE; Keech A; McGuire DK; Smith SR; Abrahamsen T; Francis BH; Miao W; Perdomo CA; Satlin A; Wiviott SD; Sabatine MS
Am Heart J; 2018 Aug; 202():39-48. PubMed ID: 29803985
[TBL] [Abstract][Full Text] [Related]
75. Lessons from the ACCOMPLISH trial.
Izzo JL
Pol Arch Med Wewn; 2009 Jun; 119(6):344-6. PubMed ID: 19694213
[No Abstract] [Full Text] [Related]
76. Effectiveness of Levoamlodipine Maleate for Hypertension Compared with Amlodipine Besylate: a Pragmatic Comparative Effectiveness Study.
Ma W; Sun N; Duan C; Zhao L; Hua Q; Sun Y; Dang A; Gao P; Qu P; Cui W; Zhao L; Dong Y; Cui L; Qi X; Jiang Y; Xie J; Li J; Wu G; Du X; Huo Y; Chen P;
Cardiovasc Drugs Ther; 2021 Feb; 35(1):41-50. PubMed ID: 32915349
[TBL] [Abstract][Full Text] [Related]
77. Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
Zhang X; Lynch AI; Davis BR; Ford CE; Boerwinkle E; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
PLoS One; 2012; 7(3):e34217. PubMed ID: 22470539
[TBL] [Abstract][Full Text] [Related]
78. Burden and rates of treatment and control of cardiovascular disease risk factors in obesity: the Framingham Heart Study.
Molenaar EA; Hwang SJ; Vasan RS; Grobbee DE; Meigs JB; D'Agostino RB; Levy D; Fox CS
Diabetes Care; 2008 Jul; 31(7):1367-72. PubMed ID: 18375414
[TBL] [Abstract][Full Text] [Related]
79. Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension.
Hripcsak G; Suchard MA; Shea S; Chen R; You SC; Pratt N; Madigan D; Krumholz HM; Ryan PB; Schuemie MJ
JAMA Intern Med; 2020 Apr; 180(4):542-551. PubMed ID: 32065600
[TBL] [Abstract][Full Text] [Related]
80. [Overweight and obesity in hypertensive Spanish patients. The CORONARIA study].
Cosín Aguilar J; Hernándiz Martínez A; Masramón Morell X; Arístegui Urrestarazu R; Aguilar Llopis A; Zamorano Gómez JL; Armada Peláez B; Rodríguez Padial L
Med Clin (Barc); 2007 Nov; 129(17):641-5. PubMed ID: 18005629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
